Pharma & Biotech

Novo Nordisk is navigating a pivotal moment. The pharmaceutical giant is nearing the completion of a significant cost-cutting initiative that...

Investor focus has intensified on Insmed Incorporated this week, driven by promising clinical data presentations and a notably bullish assessment...

Catalyst Pharmaceuticals concluded January with a robust operational update, showcasing significant strategic momentum. The company's third-quarter results for 2025 revealed...

Biotechnology firm Ocugen has bolstered its financial position through a recent capital raise, providing crucial resources as it approaches significant...

Biopharmaceutical company Viking Therapeutics has moved its lead obesity treatment candidate into the final stage of clinical development, following the...

As the market anticipates its upcoming financial release, Iqvia has announced a significant expansion of its strategic footprint through a...

Protalix Biotherapeutics is entering a period defined by significant upcoming regulatory and clinical milestones. Following a strategic update in early...

Eli Lilly & Co. is executing a rapid and ambitious strategy to broaden its therapeutic reach. In a concentrated burst...

The telemedicine provider Hims & Hers is navigating a complex competitive landscape. Amid recent pressure on its share price, the...

Biotechnology firm VolitionRX Ltd. enters a critical period marked by two significant corporate developments: the release of fresh clinical study...